Tailoring photosensitive ROS for advanced photodynamic therapy

Exp Mol Med. 2021 Apr;53(4):495-504. doi: 10.1038/s12276-021-00599-7. Epub 2021 Apr 8.

Abstract

Photodynamic therapy (PDT) has been considered a noninvasive and cost-effective modality for tumor treatment. However, the complexity of tumor microenvironments poses challenges to the implementation of traditional PDT. Here, we review recent advances in PDT to resolve the current problems. Major breakthroughs in PDTs are enabling significant progress in molecular medicine and are interconnected with innovative strategies based on smart bio/nanomaterials or therapeutic insights. We focus on newly developed PDT strategies designed by tailoring photosensitive reactive oxygen species generation, which include the use of proteinaceous photosensitizers, self-illumination, or oxygen-independent approaches. While these updated PDT platforms are expected to enable major advances in cancer treatment, addressing future challenges related to biosafety and target specificity is discussed throughout as a necessary goal to expand the usefulness of PDT.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biological Therapy
  • Biomarkers, Tumor
  • Cell Death
  • Disease Management
  • Humans
  • Luminescent Proteins / genetics
  • Luminescent Proteins / metabolism
  • Neoplasms / diagnosis
  • Neoplasms / etiology
  • Neoplasms / metabolism*
  • Neoplasms / therapy*
  • Oxidation-Reduction
  • Oxidative Stress
  • Photochemotherapy* / adverse effects
  • Photochemotherapy* / methods
  • Photosensitizing Agents / chemistry
  • Photosensitizing Agents / metabolism*
  • Reactive Oxygen Species / chemistry
  • Reactive Oxygen Species / metabolism*
  • Signal Transduction
  • Tumor Microenvironment

Substances

  • Biomarkers, Tumor
  • Luminescent Proteins
  • Photosensitizing Agents
  • Reactive Oxygen Species